CVS Health Corporation CVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 418.16B | 412.65B | 405.62B | 399.83B | 391.69B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 418.16B | 412.65B | 405.62B | 399.83B | 391.69B |
| Cost of Revenue | 360.78B | 356.34B | 351.32B | 346.71B | 339.39B |
| Gross Profit | 57.38B | 56.31B | 54.30B | 53.13B | 52.30B |
| SG&A Expenses | 44.61B | 44.15B | 43.46B | 43.11B | 42.15B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 405.38B | 400.49B | 394.77B | 389.82B | 381.54B |
| Operating Income | 12.77B | 12.16B | 10.85B | 10.02B | 10.15B |
| Income Before Tax | 12.12B | 5.79B | 3.46B | 2.14B | 2.91B |
| Income Tax Expenses | 1.07B | 902.00M | 554.00M | 408.00M | 2.48B |
| Earnings from Continuing Operations | 11.05K | 4.89K | 2.90K | 1.73K | 428.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.00M | 5.00M | 29.00M | 40.00M | 41.00M |
| Net Income | 11.04B | 4.89B | 2.93B | 1.77B | 469.00M |
| EBIT | 12.77B | 12.16B | 10.85B | 10.02B | 10.15B |
| EBITDA | 17.29B | 16.68B | 15.41B | 14.63B | 14.75B |
| EPS Basic | 8.65 | 3.83 | 2.30 | 1.40 | 0.39 |
| Normalized Basic EPS | 5.95 | 5.65 | 4.96 | 4.54 | 4.71 |
| EPS Diluted | 8.60 | 3.78 | 2.27 | 1.38 | 0.38 |
| Normalized Diluted EPS | 5.92 | 5.62 | 4.94 | 4.53 | 4.70 |
| Average Basic Shares Outstanding | 5.10B | 5.09B | 5.08B | 5.07B | 5.06B |
| Average Diluted Shares Outstanding | 5.13B | 5.11B | 5.10B | 5.08B | 5.06B |
| Dividend Per Share | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
| Payout Ratio | 31.01% | 69.86% | 116.10% | 192.14% | 722.81% |